To catheterize the CS, a sheath isused in first intention in 81%. CS angiography is performed in 90%, with an inflated balloon in 59%.
Methods:
Forty eight patients who received small-caliber leads of the Riata family (models 1570, 1572, 1580, 1582, 7000, 7002) in our institution between May 2002 and March 2008 were systematically called for an additional visit including face-profile thoracic fluoroscopy to ascertain integrity of the leads followed by routinely repeated fluoroscopies at every six-month visits. We assessed the prevalence of insulation defects with externalized cables and their relation with adverse events requiring lead revision. We tried to evaluate the time lag for emergence of their electrical dysfunction.
Results: Thirty five patients, mean age=64±10 years, with at least 7-month completed fluoroscopy follow-up were included in analysis. After 55-month mean follow-up, 57% of patients completed 2 or more spaced fluoroscopies. Externalized conductors were identified in 7 (20%) patients after a 48-months (12-114) mean delay and in 4 (11%) cases the images were classified as borderline. Three of 7 patients with insulation damage required lead replacement for the reason of clinical adverse events. In two other patients an increase of abrasion was observed on repeated fluoroscopy without changes in electrical parameters.
Conclusion:
Insulation damage with externalized conductors was identified in 20% of patients implanted with Riata leads. Routine fluoroscopic screening allowed earlier detection of these defects and may be useful for their closer monitoring and better management.
Is myotonic dystrophy part of the Brugada syndrome? Results of ajmaline challenge in Steinert disease
Philippe Maury (1), Mathieu Audoubert (2), Frank Raczka (3), Alexandre Duparc (4), Pierre Mondoly (1), Anne Gardères-Rollin (1) Results: 8 pts (18%) present type 1 ST elevation in the right precordial leads after ajmaline infusion. Brugada pattern was more often seen in men: 7/27 (26%) vs 1/17 (6%) (p=0.09). Patients with negative ajmaline test presented more often with fascicular block: 13/35 (27%) versus none (p=0.03).
Brugada pattern was not correlated to age, symptoms, PR interval, QRS, QT or QTc durations, HV interval (at baseline or after ajmaline), presence of bundle branch block, of late potentials at SA-ECG or inducibility of ventricular arrhythmias at EP study.
Nine pts were implanted with a pace maker and four with an ICD. Significant or symptomatic bradycardia did not happen in any non implanted pts, while only one pt presented with malignant ventricular arrhythmias during the 6.3±2.6 years follow-up (ventricular fibrillation with hypokaliemia in an ajmaline negative pt).
Conclusion:
Brugada ECG pattern can be elicited by class 1 drug in 18% of Steinert disease pts and especially in men. Presence of type 1 ST elevation under class 1 drug in Steinert disease do not seem to have some significant clinical or ECG correlations.
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A simple method to implant epicardial AICD using two separated coils Purpose: Surgical epicardial AICD implantation has been quite abandoned since developpement of endocardial leads and decrease in AICD size. Epicardial patches did not improve since 30 years, are rigid and need to be sewed to the epicard which favors bleeding. In some rare cases, epicardial AICD implantation remains indicated. Therefore we tested a new simple implant technique in 5 patients undergoing open chest surgery trough a median sternotomy.
Methods:
In 3 cases surgery was performed for percutaneous infected lead extraction failure. The two other patients required surgical operation and AICD implant (one for mitral valve regurgitation, one for tricuspid repair). A screw-in bipolar pace/sense lead (St Jude MyodexTM 1084T) was placed on the right ventricular free wall and two defibrillation leads (Medtronic Transvene®6937) were respectively sewed on the pulmonary artery trunk and on the diaphragmatic wall of the right ventricle and then connected to an AICD (Biotronik Lumax 540) placed in an abdominal pocket.
Results: Best defibrillation configuration (31 J tested) was obtained with a shock delivered between the two coils (AICD passive), from the inferior one to the superior one. There were no major cardiovascular complications. Clinical and telemonitoring follow up (mean 10 months) showed stable ventricular stimulation and detection thresholds as well as lead and coil impedances. No arrhythmias occurred.
Conclusions:
Epicardial AICD implantation is feasible in a simple way. Long term follow up is needed to confirm post operative results.
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